For five years, my parents told people I was the Harper family’s cautionary tale—the daughter who had abandoned Boston, run off to California, and never quite figured her life out. What they didn’t know was that while they were quietly mourning my “failure,” I was quietly building a health-tech company that would eventually be valued at $340 million.

That night I went home and stayed awake until four in the morning building the first prototype of what would become Metalink.

For six months, I worked my day job and built at night. My studio turned into a nest of code, whiteboards, sticky notes, and overheated hardware balanced on old textbooks for airflow. I lived on coffee, noodles, cheap eggs, and stubbornness. When I finally showed Harold the architecture, he stared at it in silence for so long I thought I had misjudged everything. Then he looked at me and said, very quietly, “This is not side-project material, Allison. This is a company. It solves a billion-dollar problem. If you don’t build it, someone else will—and they won’t understand it the way you do.”

Quitting was terrifying, not because I doubted the product, but because belief does not pay Oakland rent. Still, I had saved enough to survive six months if I budgeted like an animal. So I quit, incorporated as cheaply as possible, and turned my apartment into an even more cramped office-bedroom-command center. I coded eighteen hours a day. I stopped caring what my hair looked like. Then, at a small healthcare-tech meetup full of networking wine and jargon, I demoed a working prototype. Afterward, a venture capitalist named Lena Ortiz walked up to me and said, “This solves a billion-dollar problem.” Three weeks later, I had $500,000 in seed funding, a company called Integrated Health Solutions, and a product named Metalink.

I also made a deliberate choice to stay mostly anonymous. Internally and in company materials, I used only my initials—AH—and let a more experienced executive be the outward-facing presence in some investor settings. Part of that was strategic. Female founders receive less funding and more skepticism, and I had no interest in giving bias more room than necessary. But another part was personal. I did not want my family to know. Not while the company was still fragile. Not while failure was still possible. I refused to hand them another story about “that thing Allison tried in California.”